The complete package for COVID-19 diagnostics

From PCR for diagnostics of acute cases to serological tests for differentiated detection of antibodies of different immunoglobulin classes against different SARS-CoV-2 antigens – we provide you with the appropriate tools to answer your diagnostic question.

All tests are CE-marked. Moreover, the Anti-SARS-CoV-2 ELISA (IgG) and the EURORealTime SARS-CoV-2 have been approved for use in authorised laboratories by the U.S. Food and Drug Administration (FDA) via an Emergency Use Authorization (EUA)


For diagnostics of acute COVID-19 infections

The RT-PCR is the method of choice for diagnostics of acute SARS-CoV-2 infections and allows direct virus detection. The CE-marked EURORealTime SARS-CoV-2 detects two genetic sequences of the virus in parallel and has an analytical sensitivity of 1 cp/µl.



For differentiated antibody detection

EUROIMMUN offers CE-marked ELISAs for the detection of antibodies against modified nucleocapsid protein (IgM or IgG) as well as the S1 domain of the spike protein (IgA and IgG). In combination with the IgG ELISA, capillary blood (dried blood spots – DBS) can now be also used as alternative sample material. In this way, we offer a comprehensive and highly effective package for serological COVID-19 diagnostics.


Customer feedback & references

The ELISAs are used worldwide by renowned diagnostic laboratories, reference institutes, clinics and research institutions in order to diagnose and investigate COVID-19.

Customer feedback & publications

Information material

Download flyers and further information material here.